CAROLYN DAVIDSON: Open Payments
NPI 1043440480 · MILWAUKEE, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$10,656 in 192 payments from 16 companies in 2025. Trend: 2023 $16,591 · 2024 $9,496 · 2025 $10,656
Speaker / faculty: $6,875Food & beverage: $3,568Education: $151Travel & lodging: $62
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 29 | $7,329 |
| Teva Pharmaceuticals USA, Inc. | 13 | $590 |
| Axsome Therapeutics, Inc. | 23 | $547 |
| Otsuka America Pharmaceutical, Inc. | 24 | $524 |
| Vanda Pharmaceuticals Inc. | 31 | $420 |
| Almatica Pharma LLC | 17 | $307 |
| Neurocrine BioSciences, Inc. | 15 | $256 |
| Alkermes, Inc. | 13 | $245 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $172 |
| Collegium Pharmaceutical, Inc. | 4 | $81 |
Products named: VRAYLAR, REXULTI, Auvelity, AUSTEDO XR, FANAPT, LOREEV XR, INGREZZA, ARISTADA.
Industry payments across WI — which companies pay providers there.
